Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000330

Drug Information
NameFexofenadine    
SynonymsKBio3_002742; STOCK6S-26154; KBio2_007585; L000869; 4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid; HSDB 7486; CID3348; 76815-58-2; Fexofenadine [INN:BAN]; UNII-E6582LOH6V; NCGC00092389-02; CHEBI:5050; Spectrum4_000204; Terfenidine carboxylate, MDL 16455; Lopac0_000488; D07958; NCGC00015453-06; Fexofenadine (INN); 2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid; C06999; 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid; Carboxyterfenadine; MDL 16455; Terfenadine acid metabolite; fexofenadine; 159389-12-5; KBio2_005017; Spectrum2_001179; CHEMBL914; DB00950; Spectrum_001914; LS-28827; AC1L1FQB; MolPort-002-508-207; KBioSS_002456; F 9427; KBio2_002449; NCGC00092389-03; NCGC00015453-03; EU-0100488; Benzeneacetic acid, 4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethyl-; STK624102; BSPBio_003521; Fexofendine; SPBio_001197; Terfenadine-COOH; Telfast (TN); C32H39NO4; Terfenadine carboxylate; KBioGR_000807; BRD-A73368467-003-02-8; Spectrum5_001474; Spectrum3_001921; 83799-24-0    
Trade NameAllegra; Telfast; Fastofen; Tilfur    
CompanySanofi-Aventis    
IndicationAllergic rhinitisApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnti-Allergic Agents    
CAS NumberCAS 83799-24-0
FormularC32H39NO4    
PubChem Compound IDCID 3348.    
PubChem Substance IDSID 9212.    
ChEBI5050;    
SuperDrug ATC IDR06AX26;    
SuperDrug CAS ID083799240;    
TargetHistamine H1 receptorAntagonist[2][3]
Ref 1Comparative tolerability of second generation antihistamines. Drug Saf. 1999 May;20(5):385-401. To Reference
Ref 2Update on prescription and over-the-counter histamine inverse agonists in rhinitis therapy. Curr Allergy Asthma Rep. 2009 Mar;9(2):140-8. To Reference
Ref 3Nat Rev Drug Discov. 2003 Jan;2(1):38-51.Knockouts model the 100 best-selling drugs--will they model the next 100? To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543